B-FACT, BORDERLINE FACTOR ASSAY CONTROL— 510(k) K945854

Substantially Equivalent

George King Bio-Medical, Inc.

FDA 510(k) clearance K945854 for B-FACT, BORDERLINE FACTOR ASSAY CONTROL, Substantially Equivalent on 1995-10-24. Applicant: George King Bio-Medical, Inc..

Clearance details

Applicant
George King Bio-Medical, Inc.
Product code
Code GGN
Advisory panel
Hematology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Overland Park, KS, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.